Cargando…
Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review
BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT fin...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511321/ https://www.ncbi.nlm.nih.gov/pubmed/26273398 http://dx.doi.org/10.1111/1759-7714.12197 |
_version_ | 1782382313274867712 |
---|---|
author | Scagliori, Elena Evangelista, Laura Panunzio, Annalori Calabrese, Fiorella Nannini, Nazarena Polverosi, Roberta Pomerri, Fabio |
author_facet | Scagliori, Elena Evangelista, Laura Panunzio, Annalori Calabrese, Fiorella Nannini, Nazarena Polverosi, Roberta Pomerri, Fabio |
author_sort | Scagliori, Elena |
collection | PubMed |
description | BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT findings documented were qualitative and quantitative. Both qualitative and semiquantitative data were recovered by PET/CT. The comparisons among histological entities, outcome, and qualitative data from CT and PET/CT were made by non-parametric analysis. RESULTS: PET/CT resulted positive in 15/17 patients with thymoma. CT was available in 5/9 (56%) patients with thymic cancer and in 3/17 with thymoma. All quantitative CT parameters were significantly higher in patients with thymic cancer than thymoma (maximum axial diameter: 45 vs. 20 mm, maximum longitudinal diameter: 69 vs. 21 mm and volume: 77.91 vs. 4.52 mL; all P < 0.05). Conversely, only metabolic tumor volume (MTV) and total lesion glycolysis were significantly different in patients with thymic cancer than thymoma (126.53 vs. 6.03 cm3 and 246.05 vs. 20.32, respectively; both P < 0.05). After a median follow-up time of 17.45 months, four recurrences of disease occurred: three in patients with thymic cancer and one with a type B2 thymoma. CT volume in patients with recurrent disease was 102.19 mL versus a median value of 62.5 mL in six disease-free patients. MTV was higher in the recurrent than disease-free patient subset (143.3 vs. 81.13 cm(3)), although not statistically significant (P = 0.075). CONCLUSION: Our preliminary results demonstrated that both morphological and metabolic volume could be useful from a diagnostic and prognostic point of view in thymic cancer and thymoma patients. A large multi-center clinical trial experience for confirming the findings of this study seems mandatory. |
format | Online Article Text |
id | pubmed-4511321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45113212015-08-13 Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review Scagliori, Elena Evangelista, Laura Panunzio, Annalori Calabrese, Fiorella Nannini, Nazarena Polverosi, Roberta Pomerri, Fabio Thorac Cancer Original Articles BACKGROUND: To evaluate the role of computed tomography (CT) and positron emission tomography (PET)/CT in patients with thymic cancer and thymoma at initial staging. METHODS: We retrospectively reviewed CT and PET/CT scans of 26 patients with a thymic cancer (n = 9) or thymoma (n = 17). Chest CT findings documented were qualitative and quantitative. Both qualitative and semiquantitative data were recovered by PET/CT. The comparisons among histological entities, outcome, and qualitative data from CT and PET/CT were made by non-parametric analysis. RESULTS: PET/CT resulted positive in 15/17 patients with thymoma. CT was available in 5/9 (56%) patients with thymic cancer and in 3/17 with thymoma. All quantitative CT parameters were significantly higher in patients with thymic cancer than thymoma (maximum axial diameter: 45 vs. 20 mm, maximum longitudinal diameter: 69 vs. 21 mm and volume: 77.91 vs. 4.52 mL; all P < 0.05). Conversely, only metabolic tumor volume (MTV) and total lesion glycolysis were significantly different in patients with thymic cancer than thymoma (126.53 vs. 6.03 cm3 and 246.05 vs. 20.32, respectively; both P < 0.05). After a median follow-up time of 17.45 months, four recurrences of disease occurred: three in patients with thymic cancer and one with a type B2 thymoma. CT volume in patients with recurrent disease was 102.19 mL versus a median value of 62.5 mL in six disease-free patients. MTV was higher in the recurrent than disease-free patient subset (143.3 vs. 81.13 cm(3)), although not statistically significant (P = 0.075). CONCLUSION: Our preliminary results demonstrated that both morphological and metabolic volume could be useful from a diagnostic and prognostic point of view in thymic cancer and thymoma patients. A large multi-center clinical trial experience for confirming the findings of this study seems mandatory. John Wiley & Sons, Ltd 2015-07 2015-07-02 /pmc/articles/PMC4511321/ /pubmed/26273398 http://dx.doi.org/10.1111/1759-7714.12197 Text en © 2014 The Authors. Thoracic Cancer published by Tianjin Lung Cancer Institute and Wiley Publishing Asia Pty Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Scagliori, Elena Evangelista, Laura Panunzio, Annalori Calabrese, Fiorella Nannini, Nazarena Polverosi, Roberta Pomerri, Fabio Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title | Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title_full | Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title_fullStr | Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title_full_unstemmed | Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title_short | Conflicting or complementary role of computed tomography (CT) and positron emission tomography (PET)/CT in the assessment of thymic cancer and thymoma: our experience and literature review |
title_sort | conflicting or complementary role of computed tomography (ct) and positron emission tomography (pet)/ct in the assessment of thymic cancer and thymoma: our experience and literature review |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511321/ https://www.ncbi.nlm.nih.gov/pubmed/26273398 http://dx.doi.org/10.1111/1759-7714.12197 |
work_keys_str_mv | AT scagliorielena conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT evangelistalaura conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT panunzioannalori conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT calabresefiorella conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT nannininazarena conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT polverosiroberta conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview AT pomerrifabio conflictingorcomplementaryroleofcomputedtomographyctandpositronemissiontomographypetctintheassessmentofthymiccancerandthymomaourexperienceandliteraturereview |